Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why MeetMe Inc (MEET), La Jolla Pharmaceutical Co. (LJPC), & Sorrento Therapeutics Inc (SRNE) Surged Last Week

Page 1 of 2

MeetMe Inc (NASDAQ:MEET), La Jolla Pharmaceutical Co. (NASDAQ:LJPC), and Sorrento Therapeutics Inc (NASDAQ:SRNE) experienced a formidable surge on the stock market last week. What was the impetus driving big gains in these stocks and did hedge funds predict their upward momentum? Let’s take a look at the activity in these stocks and find out.

arrow, data, up, rising

We don’t just track the latest moves of hedge funds. We are, in fact, more interested in their 13F filings, which we use to determine the top 15 small-cap stocks held by the funds we track. We gather and share this information based on 16 years of research which showed that these 15 most popular small-cap picks have a great potential to outperform the market, beating the S&P 500 Total Return Index by nearly one percentage point per month in backtests, and easily beating the most popular large-cap picks of funds, which nonetheless get the majority of their collective capital. Why pay fees to invest in both the best and worst ideas of a particular hedge fund when you can simply mimic only the very best ideas of the best fund managers on your own? Since the beginning of forward testing in August 2012, the Insider Monkey small-cap strategy has outperformed the market every year, returning 145%, nearly 2.5 times greater returns than the S&P 500 during the same period (see more details).

MeetMe Inc (NASDAQ:MEET), the location-based social network, raised its revenue and EBITDA guidance for the second quarter last week, which led to a massive spike in the shares of the company on Tuesday. The company now expects revenue of $10.5 million to $10.7 million in the second quarter, up from its previous guidance of $9 million to $9.5 million. After the guidance change announcement on Tuesday, MeetMe Inc (NASDAQ:MEET)’s stock went up by 11.1% to $1.44 and surged by another 28.5% to $1.85 on Wednesday. The company says that it has raised its expectations for the second quarter because of a dramatic increase in its app ads revenue. According to Geoff Cook, CEO of MeetMe Inc (NASDAQ:MEET), the ads revenue in the first three weeks of June went up by 23% compared to the May average. Overall hedge fund activity on the stock was neutral, with ownership dipping to five funds through the end of the first quarter from six at the end of 2014, while aggregate investments rose to $14.13 million from $11.74 million. Joseph Jolson‘s Harvest Capital Strategies is the largest shareholder in our database, owning 4.56 million shares.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!